Vaccines, blood, antisera, toxins and cultures in   Poland

Exports In 2023, Poland exported $993M in Vaccines, blood, antisera, toxins and cultures, making it the 22nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 79th most exported product in Poland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Poland are: Belgium ($148M), Netherlands ($102M), Hungary ($98.4M), France ($62.2M), and Sweden ($59.5M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Poland between 2022 and 2023 were Hungary ($94.2M), Denmark ($38.2M), and Austria ($31.9M).

Imports In 2023, Poland imported $3.85B in Vaccines, blood, antisera, toxins and cultures, becoming the 18th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 10th most imported product in Poland. Poland imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($888M), Italy ($680M), Germany ($445M), Belgium ($395M), and Switzerland ($312M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Poland between 2022 and 2023 were South Korea ($163M), Switzerland ($155M), and Hungary ($100M).